Looking to list your Masters programmes? Log in here.
About the course
This programme gives you a thorough grounding in the scientific principles underlying cancer treatment.
You’ll discover how new treatments are developed, evaluated and implemented. By the end of the course you’ll be equipped with a thorough knowledge of cancer biology and pathology, research methodologies, drug development, and regulatory issues.
You’ll have a firm grounding in the use and evaluation of cancer therapies, which will enhance your career prospects in many areas of cancer research, including early phase clinical trials.
You’ll also take a three-month dissertation under the supervision of one of our research experts. This may involve setting up a ‘mock’ clinical trial to gain experience of clinical research and drug development in the cancer setting.
Entry Requirements
The programme is open to graduate scientists, clinicians and other medical professionals working in healthcare, the pharmaceutical industry or contract research organisations.
Applicants should have a minimum 2:1 degree in relevant subject (eg, biology/chemistry/pharmacology/medicine), or degree equivalent qualification from a recognised academic institution or an appropriate professional qualification or experience. A 2:2 degree will be considered with strong supporting evidence.
Register your interest for this programme
Please correct the errors indicated below to send your enquiry
The information you submit to Queen Mary University of London will only be used by them or their data partners to deal with your enquiry, according to their privacy notice. For more information on how we use and store your data, please read our privacy statement.